DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Ezatiostat is an investigational drug.
There have been 7 clinical trials for Ezatiostat. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2008.
The most common disease conditions in clinical trials are Preleukemia, Myelodysplastic Syndromes, and Syndrome. The leading clinical trial sponsors are Telik and [disabled in preview].
Recent Clinical Trials for Ezatiostat
|Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome||Telik||Phase 2|
|Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome||Telik||Phase 2|
|Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)||Telik||Phase 1|